Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer
Personalised medicine, an essential component of modern thoracic oncology, has been evolving continuously ever since the discovery of the epidermal growth factor receptor and its tyrosine kinase inhibitors. Today, screening for driver alterations in patients with advanced lung adenocarcinoma as well...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2021-07-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/30/161/200294.full |